Janssen announced the approval of the FDA for the antiviral drug Symtuza
On Tuesday, July 17th, the pharmaceutical company Janssen, part of the Johnson & Johnson structure, issued a statement approving the drug for the treatment of HIV-1 Symtuza by the US Food and Drug Administration (FDA). A drug that is a combination of darunavir / cobicystate ...